Column chromatography is a method used to separate individual chemical compounds from a mixture, which is frequently used in several industries including pharmaceutical and biotechnology, food and beverage, water and environment, nutraceuticals, academics, research institutes, and analytical laboratories. With prepacked column chromatography now available, the acceptance for the same is surging. A report by Transparency Market Research estimates the global market for prepacked chromatography column to expand at a CAGR of 8.4% during the forecast period of 2016–2024, reaching a valuation of US$3.3 bn by the end of 2024.
Several factors are driving the global prepacked chromatography column market, including rising need for purification of biopharmaceuticals, government support, increase in research activities, and rising awareness through conferences and exhibitions. Although the market is dominated by GE healthcare and Repligen Corporation, who together held 78% of the shares in 2015, here are a few opportunities available for new entrants:
Increased Investments in Biosimilars
High cost of pharmaceuticals such as biologics has led to rise in healthcare costs. Hence, various companies have an increased investments in biosimilars, which is an emerging market since the factors such as safety, pricing, manufacturing, entry barriers, physician acceptance, and marketing makes the market develop differently as compared to generic markets. Moreover, the U.S. is the most prominent market for biologics and has high prices for it. This presents an opportunity for biosimilar producers.
For instance, in June 2016, Pfizer, Inc. announced that it will invest approximately US$350 mn in the development of global biotechnology in China. This will result in local production of high-quality and affordable biosimilar medicines that will benefit patients both in China and across the world.
Rising Demand for Single-use Prepacked Chromatography Solutions
Single-use disposable devices and accessories have been a well-recognized technology in the biopharmaceutical industry. Currently, several single use chromatography column systems are available that meet regulatory the industry standards. Moreover, these single-use chromatography colums have several key features such as scalability, reproducibility, ease of use, and operator safety. Therefore single use chromatography coumns meet end-user demand for robust and efficient purification steps and thus continue to interest the manufacturers to bring new innovative products to the downstream processes.